P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro

Abstract

The metabolic anomalies and genetic predisposition have found to accelerate tau-mediated neurodegeneration and prove detrimental for the early-onset of Alzheimer's disease.